Extracellular signal-regulated kinase 1/2 involvement in the enhancement of contextual fear conditioning by nicotine

Behav Neurosci. 2007 Oct;121(5):1119-24. doi: 10.1037/0735-7044.121.5.1119.

Abstract

Contextual fear conditioning is enhanced by nicotine, but the cellular mechanisms underlying this effect are unknown. Extracellular signal regulated kinase 1/2 (ERK 1/2) has been shown to play an integral role in the formation of contextual fear memories. As such, it is possible that ERK 1/2 is involved in the enhancement of contextual fear conditioning by nicotine. To determine whether ERK 1/2 plays a role in this enhancement, a dose of SL327 (a selective, systemic ERK 1/2 inhibitor) that is subthreshold for inhibiting contextual fear conditioning was coadministered with nicotine prior to training, testing, or both training and testing of contextual fear conditioning in C57BL/6 mice. When administered prior to training, this subthreshold dose of SL327 attenuated the enhancement of contextual fear conditioning by nicotine to levels similar to those of vehicle-treated animals. When administered prior to testing, the subthreshold dose of SL327 did not significantly alter conditioning. These results suggest that activation of ERK 1/2 by nicotine during acquisition leads to an enhancement of contextual fear conditioning.

Publication types

  • Research Support, N.I.H., Extramural

MeSH terms

  • Aminoacetonitrile / analogs & derivatives
  • Aminoacetonitrile / pharmacology
  • Animals
  • Conditioning, Psychological / drug effects*
  • Enzyme Inhibitors / pharmacology
  • Fear / drug effects*
  • Fear / psychology*
  • Male
  • Mice
  • Mice, Inbred C57BL
  • Mitogen-Activated Protein Kinase 1 / antagonists & inhibitors
  • Mitogen-Activated Protein Kinase 1 / physiology*
  • Mitogen-Activated Protein Kinase 3 / antagonists & inhibitors
  • Mitogen-Activated Protein Kinase 3 / physiology*
  • Nicotine / pharmacology*
  • Nicotinic Agonists / pharmacology*

Substances

  • Enzyme Inhibitors
  • Nicotinic Agonists
  • SL 327
  • Aminoacetonitrile
  • Nicotine
  • Mitogen-Activated Protein Kinase 1
  • Mitogen-Activated Protein Kinase 3